Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00100295Phase 2Completed
A Phase 2 trial of hypericum perforatum in attention deficit hyperactivity disorder (ADHD), sponsored by National Center for Complementary and Integrative Health. Started Feb 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00100295.